Scarica l'app Stockscreener
8.12
1.35%
-0.05
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$8.17
Aprire:
$8.17
Volume 24 ore:
96,461
Relative Volume:
1.10
Capitalizzazione di mercato:
$224.55M
Reddito:
$21.25M
Utile/perdita netta:
$-16.05M
Rapporto P/E:
-13.31
EPS:
-0.61
Flusso di cassa netto:
$-17.14M
1 W Prestazione:
+27.33%
1M Prestazione:
+54.70%
6M Prestazione:
+70.76%
1 anno Prestazione:
+13.20%
Intervallo 1D:
$7.98
$8.408
Intervallo di 1 settimana:
$6.20
$8.408
Portata 52W:
$3.96
$8.408
Fennec Pharmaceuticals Inc Stock (FENC) Company Profile
Nome
Fennec Pharmaceuticals Inc
Settore
Industria
Telefono
(919) 636-4530
Indirizzo
PO BOX 13628, RESEARCH TRIANGLE PARK, NC
Confronta FENC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
FENC
Fennec Pharmaceuticals Inc
|
8.13 | 178.97M | 21.25M | -16.05M | -17.14M | -0.61 |
|
ONC
Beigene Ltd Adr
|
236.16 | 24.29B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
435.20 | 110.94B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.3064 | 45.05M | 0 | 0 | 0 | 0.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
601.30 | 61.99B | 14.09B | 4.50B | 2.96B | 39.28 |
|
VRNA
Verona Pharma Plc Adr
|
73.26 | 5.75B | 0 | -153.72M | -103.81M | -2.00 |
Fennec Pharmaceuticals Inc Stock (FENC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-11-22 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2022-09-07 | Iniziato | CapitalOne | Overweight |
| 2022-08-08 | Ripresa | Craig Hallum | Buy |
| 2020-06-05 | Iniziato | Cantor Fitzgerald | Overweight |
| 2018-10-11 | Iniziato | Goldman | Buy |
Fennec Pharmaceuticals Inc Borsa (FENC) Ultime notizie
Don't Ignore The Insider Selling In Fennec Pharmaceuticals - simplywall.st
Fennec Pharmaceuticals (TSE:FRX) Reaches New 12-Month High on Insider Buying Activity - Defense World
FENC: HC Wainwright Maintains "Buy" Rating and Price Target | FENC Stock News - GuruFocus
Insider Buying: Jeffrey Hackman Acquires 15,000 Shares of Fennec Pharmaceuticals Inc (FENC) - GuruFocus
Fennec Pharma stock soars to 52-week high of $7.66 By Investing.com - Investing.com India
Fennec Pharma stock soars to 52-week high of $7.66 - Investing.com
(FENC) Long Term Investment Analysis - news.stocktradersdaily.com
Wedbush Forecasts Higher Earnings for Fennec Pharmaceuticals - Defense World
Wedbush Raises Earnings Estimates for Fennec Pharmaceuticals - Defense World
Fennec Pharmaceuticals’ Earnings Call Highlights Growth and Expansion - TipRanks
Fennec Pharmaceuticals First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
FENC: Craig-Hallum Raises Price Target for Fennec Pharmaceuticals | FENC Stock News - GuruFocus
Fennec (FENC) Receives Increased Price Target from Craig-Hallum - GuruFocus
Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q1 2025 Earnings Call Transcript - Insider Monkey
Contrasting Fennec Pharmaceuticals (NASDAQ:FENC) and VectivBio (NASDAQ:VECT) - Defense World
Fennec Pharmaceuticals Reports Strong Q1 2025 Growth - TipRanks
Fennec Pharmaceuticals Q1 2025 Earnings Call Transcript - MarketBeat
Fennec Pharmaceuticals Q1 Product Sales USD 8.8 Million - marketscreener.com
FENC Reports Strong Q1 Revenue Surpassing Expectations | FENC St - GuruFocus
Fennec Pharmaceuticals Sees Revenue Surge with Strategic Expansion in Europe - TipRanks
FENNEC PHARMACEUTICALS Earnings Results: $FENC Reports Quarterly Earnings - Nasdaq
Fennec Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update - The Manila Times
Fennec Pharmaceuticals Brief: Q1 Basic and Diluted Loss Per Common Share US$0.04 - marketscreener.com
Barclays PLC Grows Stock Position in Fennec Pharmaceuticals Inc (NASDAQ:FENC) - Defense World
Wells Fargo & Company MN Has $83,000 Position in Fennec Pharmaceuticals Inc (NASDAQ:FENC) - Defense World
Fennec Pharmaceuticals (FENC) Expected to Announce Quarterly Earnings on Tuesday - Defense World
Fennec Pharmaceuticals to Report First Quarter 2025 Financial Results on May 13, 2025 - The Manila Times
When (FENC) Moves Investors should Listen - news.stocktradersdaily.com
Recent uptick might appease Fennec Pharmaceuticals Inc. (NASDAQ:FENC) hedge funds owners after losing 32% over the past year - Yahoo Finance
Geode Capital Management LLC Raises Position in Fennec Pharmaceuticals Inc (NASDAQ:FENC) - Defense World
Fennec Pharmaceuticals Inc.'s (NASDAQ:FENC) Share Price Is Matching Sentiment Around Its Revenues - simplywall.st
Where are the Opportunities in (FENC) - news.stocktradersdaily.com
Fennec Pharmaceuticals: Top 10 Undervalued Biotechnology Industry Stocks (FRX) - The Globe and Mail
(FRX) Market Insights and Trading Signals (FRX:CA) - news.stocktradersdaily.com
(FRX) Advanced Trading Insights (FRX:CA) - news.stocktradersdaily.com
Norgine introduces PEDMARQSI in Germany for pediatric cancer care - MSN
(FENC) Technical Pivots with Risk Controls - news.stocktradersdaily.com
Breakeven Is Near for Fennec Pharmaceuticals Inc. (NASDAQ:FENC) - Yahoo
Fennec Pharmaceuticals director Raykov Rosty sells $52,500 in shares By Investing.com - Investing.com South Africa
Fennec Pharmaceuticals director Raykov Rosty sells $52,500 in shares - Investing.com
Vitro Diagnostics (OTCMKTS:VODG) & Fennec Pharmaceuticals (NASDAQ:FENC) Head to Head Survey - Defense World
Fennec Pharmaceuticals (TSE:FRX) Share Price Passes Below 50 Day Moving Average – Should You Sell? - Defense World
Fennec Pharmaceuticals Inc (NASDAQ:FENC) Shares Purchased by Charles Schwab Investment Management Inc. - Defense World
(FENC) Investment Analysis and Advice - news.stocktradersdaily.com
Fennec Pharmaceuticals Achieves Strong Growth and Expands Market Reach in 2024 - TipRanks
Long Term Trading Analysis for (FRX) (FRX:CA) - news.stocktradersdaily.com
(FRX) Stock Market Analysis (FRX:CA) - news.stocktradersdaily.com
(FENC) Technical Data - news.stocktradersdaily.com
(FRX) Equity Market Report (FRX:CA) - news.stocktradersdaily.com
Q1 EPS Forecast for Fennec Pharmaceuticals Raised by Analyst - Defense World
HC Wainwright Has Positive Forecast for TSE:FRX Q1 Earnings - Defense World
Fennec Pharmaceuticals Inc Azioni (FENC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Fennec Pharmaceuticals Inc Azioni (FENC) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Hackman Jeffrey S. | Chief Executive Officer |
May 16 '25 |
Buy |
6.75 |
1,035 |
6,986 |
1,035 |
| Raykov Rosty | Director |
May 16 '25 |
Sale |
6.78 |
16,667 |
113,002 |
70,254 |
0.76%
2.08%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):